Summary
Instrumentation Laboratory Company (IL), a subsidiary of Werfen Life Group, is a medical device company with focus on in vitro diagnostics (IVD) devices. The company develops, manufactures, and distributes IVD instruments, related reagents and controls for hospitals and clinical laboratories. Its major products include critical care systems including whole blood analyzers, CO-Oximeter and whole-blood coagulation system; hemostasis systems including testing systems, reagents, controls and calibrators; and information management systems. IL also offers various quality control products; and services such as advanced automation, quality management, clinical support and product support. The company offers its products to hospitals and independent clinical laboratories the world over. IL is headquartered in Bedford, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Instrumentation Laboratory Company
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
'
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Instrumentation Laboratory Company Company Overview 7
Instrumentation Laboratory Company Company Snapshot 7
Instrumentation Laboratory Company Pipeline Products and Ongoing Clinical Trials Overview 7
Instrumentation Laboratory Company – Pipeline Analysis Overview 10
Business Description 10
Instrumentation Laboratory Company - Key Facts 10
Instrumentation Laboratory Company - Major Products and Services 11
Instrumentation Laboratory Company Pipeline Products by Development Stage 13
Instrumentation Laboratory Company Pipeline Products Overview 16
ACL AcuStar - aß2GPI Domain I Assay 16
ACL AcuStar - aß2GPI Domain I Assay Product Overview 16
ACL AcuStar - HIT IgG Test 17
ACL AcuStar - HIT IgG Test Product Overview 17
ACL AcuStar - HIT Total ab Test 18
ACL AcuStar - HIT Total ab Test Product Overview 18
ACL AcuStar - VWF: RCo Assay 19
ACL AcuStar - VWF: RCo Assay Product Overview 19
ACL AcuStar - VWF:Ag Assay 20
ACL AcuStar - VWF:Ag Assay Product Overview 20
ACL TOP 300 CTS system - Global Protein C Pathway Test 21
ACL TOP 300 CTS system - Global Protein C Pathway Test Product Overview 21
ACL TOP 300 CTS System - HIT Assay 22
ACL TOP 300 CTS System - HIT Assay Product Overview 22
ACL TOP 300 CTS System - VWF-Ristocetin Cofactor 23
ACL TOP 300 CTS System - VWF-Ristocetin Cofactor Product Overview 23
ACL TOP 500 CTS System - Global Protein C Pathway Test 24
ACL TOP 500 CTS System - Global Protein C Pathway Test Product Overview 24
ACL TOP 500 CTS System - HIT Test 25
ACL TOP 500 CTS System - HIT Test Product Overview 25
ACL TOP 500 CTS System - VWF - Ristocetin Cofactor 26
ACL TOP 500 CTS System - VWF - Ristocetin Cofactor Product Overview 26
ACL TOP 700 - HIT Test 27
ACL TOP 700 - HIT Test Product Overview 27
ACL TOP 700 CTS System - VWF - Ristocetin Cofactor 28
ACL TOP 700 CTS System - VWF - Ristocetin Cofactor Product Overview 28
ACL TOP 700 System - Apixaban Test 29
ACL TOP 700 System - Apixaban Test Product Overview 29
ACL TOP 700 System - Dabigatran Test 30
ACL TOP 700 System - Dabigatran Test Product Overview 30
ACL TOP 700 System - Global Protein C Pathway Test 31
ACL TOP 700 System - Global Protein C Pathway Test Product Overview 31
ACL TOP 700 System - Rivaroxaban Test 32
ACL TOP 700 System - Rivaroxaban Test Product Overview 32
ACL TOP 750 System - Apixaban Test 33
ACL TOP 750 System - Apixaban Test Product Overview 33
ACL TOP 750 System - Dabigatran Test 34
ACL TOP 750 System - Dabigatran Test Product Overview 34
ACL TOP 750 System - Rivaroxaban Test 35
ACL TOP 750 System - Rivaroxaban Test Product Overview 35
Dabigatran Calibrators 36
Dabigatran Calibrators Product Overview 36
Dabigatran Controls 37
Dabigatran Controls Product Overview 37
Dabigatran Direct Thrombin Inhibitor Assay 38
Dabigatran Direct Thrombin Inhibitor Assay Product Overview 38
GEM Premier 4000 Analyzer - BUN 39
GEM Premier 4000 Analyzer - BUN Product Overview 39
GEM Premier 4000 Analyzer - tCO2 Test 40
GEM Premier 4000 Analyzer - tCO2 Test Product Overview 40
GEM Premier 5000 - Glucose/Lactate/Total Bilirubin 41
GEM Premier 5000 - Glucose/Lactate/Total Bilirubin Product Overview 41
GEM Premier 5000 - Hemoglobin And Oxygen Saturation 42
GEM Premier 5000 - Hemoglobin And Oxygen Saturation Product Overview 42
GEM Premier 5000 - pH/pCO2/pO2 43
GEM Premier 5000 - pH/pCO2/pO2 Product Overview 43
GEM Premier 5000 System 44
GEM Premier 5000 System Product Overview 44
HemoSIL ACL AcuStar - VWF:CB Assay 45
HemoSIL ACL AcuStar - VWF:CB Assay Product Overview 45
HemosIL AcuStar HIT-Ab (PF4-H) Controls 46
HemosIL AcuStar HIT-Ab (PF4-H) Controls Product Overview 46
HemosIL AcuStar HIT-IgG (PF4-H) Assay 47
HemosIL AcuStar HIT-IgG (PF4-H) Assay Product Overview 47
HemosIL Apixaban Testing Assay 48
HemosIL Apixaban Testing Assay Product Overview 48
HemosIL FDP Assay 49
HemosIL FDP Assay Product Overview 49
POC Enzymatic Creatinine Assay 50
POC Enzymatic Creatinine Assay Product Overview 50
Rivaroxaban Calibrators 51
Rivaroxaban Calibrators Product Overview 51
Rivaroxaban Liquid Anti-Xa Assay 52
Rivaroxaban Liquid Anti-Xa Assay Product Overview 52
Instrumentation Laboratory Company - Key Competitors 53
Instrumentation Laboratory Company - Key Employees 54
Instrumentation Laboratory Company - Locations And Subsidiaries 55
Head Office 55
Other Locations & Subsidiaries 55
Recent Developments 56
Instrumentation Laboratory Company, Recent Developments 56
Dec 19, 2016: Instrumentation Laboratory Receives US FDA Clearance For New GEM Premier 5000 Critical Care Testing System 56
Oct 11, 2016: Instrumentation Laboratory Launches HemosIL AcuStar VWF:CB Assay In Europe And Other International Markets 56
Sep 26, 2016: Instrumentation Laboratory Launches HemoHub Intelligent Data Manager Worldwide 57
Aug 15, 2016: Instrumentation Laboratory Launches HemosIL ReadiPlasTin Assay Worldwide 57
Aug 11, 2016: Instrumentation Laboratory Presents New Innovations In Hemostasis At AACC Annual Meeting 58
Jul 26, 2016: Instrumentation Laboratory Receives US FDA Clearance For New HemosIL HIT-Ab(PF4-H) Assay 59
May 09, 2016: Instrumentation Laboratory Launches HemosIL Apixaban Testing Solution in Europe 59
Mar 14, 2016: Instrumentation Laboratory Reports Record Worldwide Sales In 2015 60
Dec 21, 2015: Instrumentation Laboratory Receives US FDA Clearance For New ACL TOP Family 50 Series Hemostasis Testing Systems 61
Nov 02, 2015: Instrumentation Laboratory Enters Full Commercialization Of New ACL TOP Family 50 Series Hemostasis Systems In Selected Territories 61
Appendix 63
Methodology 63
About GlobalData 65
Contact Us 65
Disclaimer 65
List of Tables
Instrumentation Laboratory Company Pipeline Products and Ongoing Clinical Trials Overview 7
Instrumentation Laboratory Company Pipeline Products by Equipment Type 8
Instrumentation Laboratory Company Pipeline Products by Indication 9
Instrumentation Laboratory Company, Key Facts 10
Instrumentation Laboratory Company, Major Products and Services 11
Instrumentation Laboratory Company Number of Pipeline Products by Development Stage 13
Instrumentation Laboratory Company Pipeline Products Summary by Development Stage 14
ACL AcuStar - aß2GPI Domain I Assay - Product Status 16
ACL AcuStar - aß2GPI Domain I Assay - Product Description 16
ACL AcuStar - HIT IgG Test - Product Status 17
ACL AcuStar - HIT IgG Test - Product Description 17
ACL AcuStar - HIT Total ab Test - Product Status 18
ACL AcuStar - HIT Total ab Test - Product Description 18
ACL AcuStar - VWF: RCo Assay - Product Status 19
ACL AcuStar - VWF: RCo Assay - Product Description 19
ACL AcuStar - VWF:Ag Assay - Product Status 20
ACL AcuStar - VWF:Ag Assay - Product Description 20
ACL TOP 300 CTS system - Global Protein C Pathway Test - Product Status 21
ACL TOP 300 CTS system - Global Protein C Pathway Test - Product Description 21
ACL TOP 300 CTS System - HIT Assay - Product Status 22
ACL TOP 300 CTS System - HIT Assay - Product Description 22
ACL TOP 300 CTS System - VWF-Ristocetin Cofactor - Product Status 23
ACL TOP 300 CTS System - VWF-Ristocetin Cofactor - Product Description 23
ACL TOP 500 CTS System - Global Protein C Pathway Test - Product Status 24
ACL TOP 500 CTS System - Global Protein C Pathway Test - Product Description 24
ACL TOP 500 CTS System - HIT Test - Product Status 25
ACL TOP 500 CTS System - HIT Test - Product Description 25
ACL TOP 500 CTS System - VWF - Ristocetin Cofactor - Product Status 26
ACL TOP 500 CTS System - VWF - Ristocetin Cofactor - Product Description 26
ACL TOP 700 - HIT Test - Product Status 27
ACL TOP 700 - HIT Test - Product Description 27
ACL TOP 700 CTS System - VWF - Ristocetin Cofactor - Product Status 28
ACL TOP 700 CTS System - VWF - Ristocetin Cofactor - Product Description 28
ACL TOP 700 System - Apixaban Test - Product Status 29
ACL TOP 700 System - Apixaban Test - Product Description 29
ACL TOP 700 System - Dabigatran Test - Product Status 30
ACL TOP 700 System - Dabigatran Test - Product Description 30
ACL TOP 700 System - Global Protein C Pathway Test - Product Status 31
ACL TOP 700 System - Global Protein C Pathway Test - Product Description 31
ACL TOP 700 System - Rivaroxaban Test - Product Status 32
ACL TOP 700 System - Rivaroxaban Test - Product Description 32
ACL TOP 750 System - Apixaban Test - Product Status 33
ACL TOP 750 System - Apixaban Test - Product Description 33
ACL TOP 750 System - Dabigatran Test - Product Status 34
ACL TOP 750 System - Dabigatran Test - Product Description 34
ACL TOP 750 System - Rivaroxaban Test - Product Status 35
ACL TOP 750 System - Rivaroxaban Test - Product Description 35
Dabigatran Calibrators - Product Status 36
Dabigatran Calibrators - Product Description 36
Dabigatran Controls - Product Status 37
Dabigatran Controls - Product Description 37
Dabigatran Direct Thrombin Inhibitor Assay - Product Status 38
Dabigatran Direct Thrombin Inhibitor Assay - Product Description 38
GEM Premier 4000 Analyzer - BUN - Product Status 39
GEM Premier 4000 Analyzer - BUN - Product Description 39
GEM Premier 4000 Analyzer - tCO2 Test - Product Status 40
GEM Premier 4000 Analyzer - tCO2 Test - Product Description 40
GEM Premier 5000 - Glucose/Lactate/Total Bilirubin - Product Status 41
GEM Premier 5000 - Glucose/Lactate/Total Bilirubin - Product Description 41
GEM Premier 5000 - Hemoglobin And Oxygen Saturation - Product Status 42
GEM Premier 5000 - Hemoglobin And Oxygen Saturation - Product Description 42
GEM Premier 5000 - pH/pCO2/pO2 - Product Status 43
GEM Premier 5000 - pH/pCO2/pO2 - Product Description 43
GEM Premier 5000 System - Product Status 44
GEM Premier 5000 System - Product Description 44
HemoSIL ACL AcuStar - VWF:CB Assay - Product Status 45
HemoSIL ACL AcuStar - VWF:CB Assay - Product Description 45
HemosIL AcuStar HIT-Ab (PF4-H) Controls - Product Status 46
HemosIL AcuStar HIT-Ab (PF4-H) Controls - Product Description 46
HemosIL AcuStar HIT-IgG (PF4-H) Assay - Product Status 47
HemosIL AcuStar HIT-IgG (PF4-H) Assay - Product Description 47
HemosIL Apixaban Testing Assay - Product Status 48
HemosIL Apixaban Testing Assay - Product Description 48
HemosIL FDP Assay - Product Status 49
HemosIL FDP Assay - Product Description 49
POC Enzymatic Creatinine Assay - Product Status 50
POC Enzymatic Creatinine Assay - Product Description 50
Rivaroxaban Calibrators - Product Status 51
Rivaroxaban Calibrators - Product Description 51
Rivaroxaban Liquid Anti-Xa Assay - Product Status 52
Rivaroxaban Liquid Anti-Xa Assay - Product Description 52
Instrumentation Laboratory Company, Key Employees 54
Instrumentation Laboratory Company, Other Locations 55
Instrumentation Laboratory Company, Subsidiaries 55
Glossary 64
List of Figures
Instrumentation Laboratory Company Pipeline Products by Equipment Type 8
Instrumentation Laboratory Company Pipeline Products by Development Stage 13
